Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Ch55 may help reduce skin scarring and fibrosis.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

The excimer laser may help hair regrow in alopecia areata patients.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Ustekinumab helped three kids with alopecia areata regrow hair.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Dutasteride 0.5 mg is safe and effective for long-term use in Korean men with hair loss.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.